Context Therapeutics

/Context Therapeutics

Context Therapeutics® is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer


Price Range
$5.00 - $5.00

Final Shares

Anticipated Date
October 20, 2021


This offering is no longer available

To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange